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Abstract: Trypanosoma brucei, as well as Trypanosoma cruzi and more than 20 species of the genus
Leishmania, form a group of flagellated protists that threaten human health. These organisms are
transmitted by insects that, together with mammals, are their natural hosts. This implies that during
their life cycles each of them faces environments with different physical, chemical, biochemical,
and biological characteristics. In this work we review how amino acids are obtained from such
environments, how they are metabolized, and how they and some of their intermediate metabolites
are used as a survival toolbox to cope with the different conditions in which these parasites should
establish the infections in the insects and mammalian hosts.
Keywords: amino acid metabolism; amino acid uptake; bioenergetics; stress management; autophagy;
host-parasite interaction
1. Introduction
Trypanosomes are a group of flagellated protists living in a wide range of associations with other
organisms, ranging from mutualism to parasitism. Inside this group we can find two genera which
include species that are pathogenic to humans: Trypanosoma and Leishmania. The genus Trypanosoma
groups two species causing human diseases: Trypanosoma cruzi and Trypanosoma brucei; in contrast,
the genus Leishmania comprises more than twenty species affecting human health. All these pathogens
have a complex life cycle involving several mammalian species and insects, which are responsible for
the main mechanisms of transmission among mammals. Therefore, the life cycles of these parasites
involve the establishment of the infection and survival inside different hosts. The different territories
that these parasites should colonize inside each kind of host determine the need for a flexible and
quickly adaptable metabolism to deal not only with their energy requirements, but also with a variety
of stressing conditions predominant in the different environments in which these organisms live [1].
Briefly, the life cycles of T. cruzi, T. brucei and Leishmania spp. are schematized in Figure 1 and can
be summarized as follows:
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Figure 1. Life cycle of TriTryps parasites (T. brucei, T. cruzi and Leishmania spp.). The names of cell forms
are abbreviated as A: amastigote, BSF: bloodstream trypomastigote, E: epimastigote, IE: intracellular
epimastigote, M: metacyclic, P: promastigote, PCF: procyclic, and T: trypomastigote (adapted from [2]).
(a) T. cruzi, the causative agent of Chagas disease, infects the insect midgut after a bloodmeal
on an infected mammal, having the non-replicative, infective trypomastigote forms circulating
in its blood. In the triatomine gut, these trypomastigotes will differentiate into the replicative
(non-infective for mammals) epimastigote forms, which are able to colonize the insect midgut.
In the posterior region of the digestive tube, parasites differentiate into the infective, non-replicative
metacyclic trypomastigotes [3]. During a next bloodmeal, the triatomine insect will defecate, expelling
metacyclic trypomastigotes, which enter into contact with the skin or mucosa of the mammal being
bitten. The parasites internalize into this new host through wounds in the skin or exposed mucosa,
and must invade cells to reach the cytosol where they differentiate into replicative forms denominated
amastigotes [4]. After several cycles of cell division, amastigotes differentiate into a transient replicative
intracellular stage named intracellular epimastigotes [5], and, finally, these epimastigote-like forms
differentiate into the infective trypomastigotes which burst from the infected cells into the extracellular
environment. Trypomastigotes can have two fates, to infect neighbor cells or to reach the bloodstream.
Once they reach the bloodstream they can infect other cells in neighboring or distant tissues, or they
can be taken up by a new insect which will transmit them to other mammals [6].
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(b) T. brucei is transmitted by the obligatory blood-feeding tsetse flies. The tsetse takes up
bloodstream forms (BSF) of T. brucei during a bloodmeal on an infected mammal [7]. Two types of
BSF can be distinguished on the basis of morphological, biochemical, and biological characteristics:
the long-slender BSF, and the stumpy BSF. Long-slender BSF are replicative, and are responsible for
the long-term parasitemia in the mammalian host. When long-slender BSF reach a certain population
density, which is sensed through a secreted “stumpy induction factor” (SIF), they differentiate into the
non-replicative stumpy forms [8]. These latter BSF forms are the only ones that are able to differentiate
into the replicative procyclic forms (PCF) inside the insect and survive in the conditions present in
the insect midgut [9]. PCF replicate and initiate their migration to the salivary gland. During this
journey, they undergo differentiation into procyclic epimastigotes, a process that is completed once
the salivary gland is reached [10]. Upon having colonized the salivary gland, they finally differentiate
into the infective, non-dividing metacyclic forms, which will be inoculated in a new mammalian host
during the next bloodmeal of the insect. Metacyclics will differentiate into long-slender BSF in order to
replicate in the bloodstream to establish the infection. Eventually, BSF can cross the blood brain barrier
and reach the central nervous system [11].
(c) Leishmania spp. are transmitted by female phlebotomine sandflies which become infected
when they take their bloodmeal on an infected mammal [12]. During the bloodmeal, phlebotomines
ingest infected macrophages, which are lysed by hydrolytic enzymes present in the insect digestive
tube. The released amastigotes differentiate into proliferative promastigotes, which start to replicate in
the midgut. Upon nutrient depletion and low pH, promastigotes differentiate into non-replicative,
infective metacyclic promastigotes, which accumulate mostly in the stomodeal valve. During a next
bloodmeal, these metacyclic forms will be inoculated into the mammalian host [13]. Components of
the sandfly saliva can function as attractors for the host macrophages, which migrate to the region
of the bite and phagocytize the Leishmania parasites [14]. Once inside the parasitophorous vacuole,
metacyclic promastigotes can differentiate into replicative amastigotes. These amastigotes secrete a
series of proteins that can modulate, or even subvert, the role of lysosomal-derived lytic enzymes,
allowing the parasites to customize the vacuole as an adequate niche for replicating and establishing
the infection [15]. The infection can spread to other phagocytic cells directly through the release of
infective amastigotes from the macrophages. Additionally, other phagocytic host cells can become
infected by the uptake of Leishmania-infected cells: intracellular amastigotes are able to induce in
their host cells an apoptosis-like process causing their phagocytosis that allows the amastigotes to
infect a new cell [15]. Cells infected with Leishmania spp. can be ingested by a (non-infected) sandfly,
which will be able to transmit it to a new mammalian host.
As mentioned above, T. brucei, T. cruzi, and Leishmania spp. have insects and mammals as hosts.
Their biology, the niches they colonize inside each host, and the mechanisms used against the host
defenses have similarities and differences. For example, T. brucei is transiently present in the insect
midgut: once they establish the infection they colonize the salivary gland. Leishmania spp. colonize the
midgut and the proboscis of the insect, and is inoculated when the insect regurgitates during their
bloodmeal. Differently, T. cruzi transit through the entire digestive tube, and eventually colonizes
its entire epithelium, including the terminal portion, and the infected parasites are expelled with the
faeces. In the mammalian host, the replicative stages of Leishmania spp. and T. cruzi are the amastigotes,
which are strictly intracellular. However, the amastigotes of Leishmania spp. are intracellularly located
in a parasitophorous vacuole in phagocytic cells (mostly macrophages), while T. cruzi (which is able to
invade almost any nucleated cell) is transiently present in a parasitophorous vacuole, and then escapes
to the host cell’s cytosol. Differently, T. brucei is strictly extracellular, and was classically assumed to
being able to colonize the bloodstream and the central nervous system [11,16]. More recently, their
ability to survive in the skin and the extracellular interstices of fat cells in adipose tissue was shown [17].
The indicated similarities and differences between these groups of organisms probably determined
that each one evolved its metabolism to survive in the different environments they colonize. In this
respect, amino acid metabolism is crucial for these parasites far beyond their conventional roles as
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sources of carbon and energy, and building blocks of proteins. In this review, we have compiled
information about the relevance of amino acid transport and metabolism for involvement in critical
biological processes during the life cycle of these parasites, such as the establishment of the infection
within the mammalian and insect hosts, differentiation, modulation of the cell cycle and resistance to
extreme stress conditions.
A note on the nomenclature used: When genome sequencing of trypanosomatid organisms was
initiated, one reference strain (or species, in the case of Leishmania) was chosen for each of three human
diseases caused by trypanosomatids (sleeping sickness, Chagas disease, and leishmaniasis). The term
TriTryps was then introduced to refer to T. brucei, T. cruzi, and L. major in most of comparative studies
among these species. Subsequently, the term TriTryps has been adopted to refer to the entire range of
human pathogenic trypanosomatids and will be used in this sense in this paper. In the case of amino
acids, the conventional three-letter code is used to refer to the L-isomers from the beginning of the text
without being specifically spelled in full at the first mention. All other abbreviations are used after
first giving the full term followed by introducing the abbreviation between parentheses. Finally, to
avoid confusion about names and identities of enzymes, we followed the IUBMB recommendations for
biochemical texts: they are identified firstly by both their more common name and their EC number.
In most of cases, an abbreviation is introduced to make the text more readable, and this abbreviation is
used further. A complete list of all enzymes cited in the text, as well as their abbreviations and EC
numbers, are found in Supplementary Table 1.
2. Amino Acid Uptake
2.1. Amino Acid Transporters and the Identification of Their Putative Genes in Trypanosomatids
Metabolite transport systems allow entry of all essential nutrients into the cells, initially to
the cytosol and, subsequently, into the respective organelles. This is, in fact, the initial step of any
metabolic pathway, allowing the incorporation of exogenous sources of carbon, nitrogen, sulfur,
and phosphorus [18,19]. The substrates of transporters have been classified into eight categories:
1: inorganic solutes; 2: carbohydrates; 3: amino acids and derivatives; 4: bases and derivatives;
5: vitamins, cofactors, signaling molecules and their precursors; 6: drugs, dyes, sterols, and toxic
substances; 7: macromolecules; and 8: miscellaneous compounds [19].
With the advent of genome sequencing of TriTryps it has been possible to identify an enormous
variety of coding sequences for amino acid transporters [20]. These genes are spread throughout
the chromosomes, in multiple loci. One of the first attempts to identify genes encoding amino
acid transporters (AAT) in trypanosomatids focused on a family grouping of H+/amino acid
symporters, the AAAP family (amino acid/auxin permease, TC 2.A.18). This family is part of the
electrochemical potential-driven transporters and includes permeases transporting multiple or single
amino acids [21,22]. Some transporters are encoded by single-copy genes, such as the T. brucei AAT11
and AAT12 (TbAAT11 and TbAAT12), others comprise gene families with multiple copies, such as
TbAAT5 (six copies) and TbAAT7 (11 copies). This diversity is also reflected in the origin of the AAT
genes. For example, AAT11, 12, 15, and 21 have been proposed to be orthologs present in T. cruzi,
T. brucei, and L. major, derived from a common ancestor. Differently, LmAAT1 seems to have originated
by tandem duplication in L. major, whereas TcAAT32/TcAAT36 might have appeared by transpositive
duplication in T. cruzi [22,23].
As will be discussed later in this review, various AAT/AAAP have been characterized and related
to particular roles beyond uptake of amino acids as nutrients, such as osmotic control, differentiation
and infection. However, a considerable number of members of both groups still remain uncharacterized.
In this context, genetic tools have been used in attempts to identify the specific function of transporters
in trypanosomatids, especially the ones related to drug resistance. For example, two independent RNAi
library screens performed in BSF T. brucei indicated that the amino acid transporter TbAAT6 is most
likely responsible for the uptake of DL-α-difluoromethylornithine (DFMO, also commercially known
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as eflornithine), because its knockdown conferred resistance against this drug [24–26]. The application
of RNAi screens in trypanosomatids is limited to T. brucei, the only species of this family in which
the RNAi machinery has been extensively used for reverse genetic approaches [27]. Predictably, the
development of high-throughput CRISPR-Cas9 for use in other trypanosomatids will facilitate the
discovery and characterization of novel amino acid transporters [28].
2.2. Biochemical Characterization of Amino Acid Transporters
Amino acids are available in both mammalian and insect hosts of TriTryps at different
concentrations and these metabolites can be consumed as energy source, what occurs mainly when they
colonize insect vectors [29–31]. Amino acid transporters with a broad range of affinities and specificities
have been described for TriTryps, probably reflecting the broad range of concentrations in which amino
acids are present in the different hosts. In this review, we will approach the biochemically-described
transport systems according to the representative groups of TriTryps.
2.2.1. Trypanosoma brucei
Early studies of amino acid transport showed that T. b. gambiense BSF take up different amino acids,
such as Ala, Arg, Asp, Glu, Gly, Leu, Lys, Met, Phe, Ser, Thr, and the non-proteinogenic amino acid
ornithine (Orn). In these studies, the authors showed that, in most cases, such uptake was mediated
by a membrane-associated transport system, but these systems were not fully characterized [32–34].
Initially, it was suggested that, based on their specificities, the transport systems formed discrete
sets (collectively named loci), each one able to take up different amino acids. Five different loci
were described: locus A transports Lys and, by binding Glu and Arg, stimulate Lys uptake; locus B
transports Thr, Gly, and Ala; locus C transports Glu, this transport being inhibited by the binding of
Phe, Met, or Thr; locus D transports Met and Phe; and locus E transports Arg and Lys, this transport
being inhibited by its binding of Met and Phe [34]. Later, the Thr transport in T. brucei BSF was assessed
at Thr concentrations close to those of the rat’s plasma, indicating a single transporter instead of
a locus [35]. Almost simultaneously, Cys transport was described in the context of the design of a
medium for axenic cultivation of BSF. Duszenko and collaborators [36] showed that these parasites
efficiently incorporated Cys, but not cystine (oxidized Cys form).
It has been shown that Pro is a main carbon source for PCF grown in glucose-depleted
conditions [37–39]. In the hemolymph of tsetse flies (Glossina species) Pro can reach concentrations
as high as 60 mM, which was assumed to be used by T. brucei parasites during the infection [2,40].
This reinforced the interest in the characterization of Pro uptake in PCF of T. b. brucei. The kinetic
characterization of Pro uptake pointed to a single high affinity active transporter (KM 0.02 mM)
inhibited by Ala and Cys [41]. It was also shown that the Vmax value in parasites cultivated in
glucose-depleted SDM80 medium was 2.6 times higher than that in parasites grown in glucose-rich
SDM79 medium, indicating that Pro transport is down-regulated in the presence of glucose [38].
More recently, the RNAi library screening approach allowed the identification of the transporter
responsible for uptake of the drug DFMO, which is TbAAT6, a low affinity transporter of neutral
amino acids, including Pro, Gly, and Trp [42]. It is noteworthy that the biochemical characteristics
(affinity and substrate specificity) reported for TbAAT6 expressed in Xenopus laevis oocytes and the
PCF Pro transport system are markedly different [38,41,42]. In addition, TbAAT6 knockdown did
not affect the growth of PCF in glucose-depleted conditions and Pro uptake rates, but it resulted in
reduced sensitivity to DFMO [42]. This supports the view that T. brucei, like T. cruzi and Leishmania spp.
(see below), expresses high-affinity and low-affinity Pro transport systems, the former being probably
responsible for Pro metabolism in glucose-depleted conditions and at low Pro concentrations, and the
latter (TbAAT6) being responsible for DFMO uptake.
Met transport systems have also been characterized in T. b. brucei [43,44]. Met uptake in both
BSF and PCF of T. b. brucei occurs by a relatively high affinity (KM 0.03 mM), proton-motive force
dependent system and is inhibited by Leu, Phe, and Trp. However, in BSF Met, uptake showed a
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broader inhibition profile: D-Met, Leu, and Gln also inhibited Met uptake efficiently. These data
suggest that different transporters are operative in the two stages [44]. Interestingly, low-affinity Met
transporters with similar kinetic properties (KM > 1 mM) have been described for T. b. brucei and T. b.
rhodesiense BSF [43].
More recently, other members of the AAT family have been characterized. TbAAT5-3 and
TbAAT16-1 have been heterologously expressed, showing high affinity for Arg and Lys (in both cases
KM in the low µM range) and high selectivity (including stereoselectivity, the D-isomer does not affect
the transport). Peculiarly, down-regulation of these transporters affected BSF growth, demonstrating
they are essential for the parasites [45]. In addition, it has been shown that T. brucei has two high-affinity
Orn transporters, TbAAT10-1 and TbAAT2-4. TbAAT10-1 is selective for Orn, whereas TbAAT2-4
transports both Orn and His, which is consistent with inhibition of TbAAT2-4-mediated Orn uptake in
the presence of high extracellular His levels. Orn uptake by both transporters is important for growth
of BSF T. brucei, probably due to their role in providing Orn for polyamine biosynthesis [46].
2.2.2. Trypanosoma cruzi
The study of amino acid uptake in T. cruzi was initiated with the demonstration that Arg and Lys
uptake was mediated by transport systems [47–49]. Lys transport was described as being performed
by three different systems, based on their sensitivity to neutral amino acids, with one of them being
inhibited by Phe and Tyr, another by Pro, Ala, Met, and Cys, and the last one by Gly and branched-chain
amino acids (BCAA), respectively [47]. Four of these amino acids that inhibit Lys transport (Gly, Val,
Met, and Ala) have also been shown to be inhibitors of Arg transport [48]. The existence of these
transport systems was also confirmed by Goldberg in T. cruzi epimastigotes [49], who proposed
that Met is an inhibitor of both transporters, and Lys is an inhibitor of Arg uptake and vice versa.
More recently, two Arg transport systems were fully characterized, a high-affinity transporter specific
for Arg and a low-affinity transporter (KM value for Arg 70-fold higher than that of the high-affinity
system), which is inhibited by Met and, to a lesser extent, by Gly, Lys, and Tyr [50,51]. Later, a gene
encoding a cationic amino-acid transporter, TcAAP7, was identified in T. cruzi. It was biochemically
characterized as a Lys permease through heterologous expression and through overexpression in
epimastigotes. No kinetic parameters were reported for the recombinantly expressed TcAAP7 protein,
but the transport activity in epimastigotes showed a KM of 23 µM. Interestingly, when epimastigotes
were subjected to starvation in PBS supplemented with either glucose or Pro, Lys uptake was increased,
whereas in Lys-supplemented PBS Lys uptake was considerably decreased. These data indicate the
existence of an energy-dependent, substrate-sensing mechanism that regulates Lys transport [52].
A gene encoding an Arg permease (TcAAAP411/TcAAP3) was identified, and the biochemical
characterization of the protein showed an activity with kinetic parameters compatible with the
high-affinity Arg transporter previously characterized by Pereira and coworkers [53]. The influence of
TcAAP3 in Arg metabolism was also studied, showing that the intracellular Arg concentration increases
and arginine kinase is significantly down-regulated in parasites that overexpressed TcAAP3 [54].
Recently, a novel transporter (TcCAT1.1) has been characterized, which was able to transport both Arg
and Orn, although it showed high affinity for Arg and low affinity for Orn [55].
Pro uptake was also investigated in T. cruzi. The kinetic analysis indicated the presence of two
relatively low-affinity active transport systems (named systems A and B) with different affinities.
System A is H+ dependent, whereas system B is presumably dependent on ATP hydrolysis. System A
is inhibited by Trp, Gly, Leu, Met, Cys, and Ala, while Cys, Ala, and Val inhibit system B [56]. A low
affinity Pro carrier (TcAAP24, the TbAAT6 ortholog), transporting both the L- and D-Pro enantiomers,
has more recently been characterized [57]. This unusual lack of stereospecificity for Pro can be related
to the reported expression of a Pro racemase in T. cruzi and Trypanosoma vivax (but not in T. brucei and
Leishmania spp.) [58].
The transport of two anionic amino acids, Asp and Glu, in T. cruzi was described to be mediated
by at least two different systems with maximal activities at lower pH [59,60]. Asp uptake occurs with
Pathogens 2018, 7, 36 7 of 45
the same high affinity and specificity (only inhibited by Glu) in the epimastigote and trypomastigote
forms. Glu transport, which was shown to be H+ dependent, occurs with 10-times less affinity than
Asp, and was inhibited by Asp, Ala, Gln, Asn, and Met [60]. Notably, the rate of Asp uptake in
epimastigotes increases upon nutrient starvation of the parasites [59], while such starvation had no
effect on Glu uptake [60].
The transport of His and Gln, two amino acids metabolically related to Glu, was also characterized.
His uptake is performed by a medium-affinity, highly specific, active system [61]. In contrast,
the highly-specific Gln transporter can be considered of low affinity, with a KM value in the mM range
(similar to that of system A for Pro transport). Like the Glu transport system, both His and Gln uptake
are H+ dependent and do not compete with other amino acids [Damasceno, F.S., Barisón, M.J., et al.,
submitted]. The transport of γ-aminobutyric acid (GABA), another Glu-related metabolite, showed
kinetic parameters close to those of Glu uptake, but involves a different mechanism. GABA uptake is
the only Na+-dependent amino acid transport characterized so far [60,62].
Cys uptake is mediated by a high-affinity system, showing an increased Vmax under nutrient
starvation and in stationary growth phase. Cys uptake seemed to be highly specific, since none of the
amino acids tested (Pro, Ser, Gly, Met, Arg, Glu) significantly affected its transport rate [63].
The uptake of all BCAA (Val, Ile, and Leu) was shown to be performed by the same transport
system, with relevant differences in affinity (KMIIe 470 µM, KMLeu 940 µM, KMVal 1960 µM) and
velocities. The system is H+ dependent and highly specific, since no other amino acids than the
branched ones were able to decrease their incorporation [64].
2.2.3. Leishmania spp.
The transport of Met was the first one studied in Leishmania spp. by Mukkada and Simon [65].
In promastigotes of L. tropica, this uptake occurs through a single system, following Michaelis-Menten
kinetics. After 10 min of Met uptake, only 20% of this amino acid is metabolized, mainly to Met
sulfoxide and cystathionine [65]. In addition, D-Met and some neutral amino acids (Ala and BCAA),
as well as internal pools of Met, Lys, and Tyr, were able to inhibit Met transport [66]. Mukkada and
collaborators [67] were also pioneers in the characterization of Pro transport in Leishmania, describing
it as an active system with broad specificity, and inhibited by Ala, Met, and Val. Later, Bonay and
Cohén [68] proposed the existence of two Na+-independent neutral amino-acid (including Met)
transporters in Leishmania, one being more specific for Ala and Pro uptake and the other more specific
for Phe and Leu uptake. The energy driving Pro transport in the L. donovani promastigotes was
determined as being a proton-motive force comprising a transmembrane pH gradient and electrical
potential [69]. Later, it was established that although the uptake of Pro has an optimal pH in the neutral
region (7.0–7.5), its dependence on the electrochemical potential is constant over the entire pH range
tested [70]. The pH dependence of Pro transport in L. donovani was also seen in intracellular forms.
Different from promastigotes, in which uptake is inhibited at an acidic pH, that in amastigotes has an
optimum at pH 5.5. Nonetheless, as in promastigotes, Pro transport is driven by the proton-motive
force [71]. Another study showed that the uptake of Pro can occur by passive transport when this
amino acid is the growth rate-limiting carbon and energy source in glucose-free conditions [72]. It is
also regulated by the extracellular pH [71], with different kinetics compared to that operating in
promastigotes grown and assayed at pH 7.0 [73]. The differences found in the transport of Pro between
L. donovani life-cycle stages suggest that Pro can be captured by more than one system. This was
confirmed by the identification of three different Pro transport systems: a cation-dependent (system A)
and a cation-independent (system B) transporter in promastigotes, and a single cation-independent
transporter in amastigotes (system C) [74]. The A and C systems have an optimum pH in the acidic
range (pH 6.0 and 5.0, respectively); they are less specific for Pro and able to mediate uptake of several
other amino acids. In contrast, system B is less sensitive to the extracellular pH and is more specific for
Pro, while only Ala, Cys, Gln, and Gly inhibit it more than 50% [74].
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Also biochemically characterized in L. donovani promastigotes is an Arg transporter that showed
a high affinity and specificity, a Na+ dependence and pH sensitivity with an optimum pH at 7.5 [75].
Two more amino-acid transport systems were characterized in L. amazonensis. First, a single Glu
transport system was found in promastigotes, which was shown to be energy dependent, sensitive to
the extracellular H+ concentration (pH optimum at 6.0) and insensitive to K+ and Na+ and susceptible
to inhibition by Gln, Asp, Asn, Ala, and Met [76]. Ser uptake was also characterized in L. amazonensis
promastigotes and amastigotes. Its kinetic analysis showed a single transport system with similar
characteristics in both forms, i.e., a medium affinity and pH responsiveness (pH optimum at 7.5).
Similarly to what was observed for the Glu transport system, it was not affected by K+ or Na+, and was
inhibited by other amino acids, in this case, Ala, Cys, Gly, Thr, and Val [77].
Some genes annotated as putatively-encoding amino-acid transporters were functionally
characterized, allowing to provide a molecular identity to some of the biochemically-characterized
systems. A neutral amino-acid transporter (LbAAP24), which was shown to transport mainly Pro
and Ala, was identified and characterized by heterologous expression. It appeared to be a transporter
with low affinity and high specificity for Pro and with an optimum pH at 6.5, identifying it as a
promastigote-specific transport system A. Interestingly, LbAAP24 plays a critical role in amino-acid
homeostasis and in hypotonic stress resistance [78]. Subsequently, an active and highly-specific,
high-affinity Arg transporter (LdAAP3) was identified and characterized, with kinetic parameters
similar to those of the system described by Kandpal et al. [79]. In addition, like for LdAAP24, a role
was shown for LdAAP3 in maintaining Arg homeostasis in promastigotes [80]. This regulation was
also reported in L. amazonensis [81,82].
Finally, transporter LdAAP7 was identified and characterized as a Lys-specific permease in
L. donovani. Biochemical analysis of LdAAP7, heterologously expressed and in promastigotes, revealed
similar kinetic parameters for Lys uptake (KM 7 µM and 3 µM, respectively), however, different pH
dependencies (pH optimum at 4.5 and 6.5, respectively) were found. In both cases, Lys uptake
was highly specific and seemed to be regulated by the intracellular Lys pool. Its overexpression
in promastigotes did not increase Lys transport. Furthermore, no uptake of Lys was observed in
stationary phase promastigotes, in agreement with the notion that, until now, Lys seems not to be
involved in other processes than the synthesis of proteins [52].
All amino acid transporters and systems that have been characterized in TriTryps are summarized
in Table 1.
Table 1. Biochemically-characterized amino acid transport systems and their genes in TriTryps.
Amino Acid T. brucei T. cruzi Leishmania spp. Gene Name
Proline a
Two systems
[38,41,42]
Two systems [54] Three systems [72]
TbAAT6 [40]
TcAAP24 [55]
LmAAP24 [76]
Glutamate One system [60] One system [76]
Glutamine
One system
(Damasceno et al.,
submitted)
Isoleucine, Leucine
and Valine b One system [64]
Aspartate One system [59]
Arginine c Two systems [48,49] One system [73]
TbAAT5-3 [45]
TcAAAP411/TcAAP3
and TcCAT1.1 [51,53]
LdAAP3 and LaAAP3
[75,79–82]
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Table 1. Cont.
Amino Acid T. brucei T. cruzi Leishmania spp. Gene Name
Ornithine d
TbAAT10-1 and
TbAAT2-4 [46]
TcCAT1.1 [55]
Histidine e One system [61] TbAAT2-4 [46]
Methionine Two systems[43,44] One system [65,66]
Lysine f One system [52] One system [52]
TbAAT16-1 [45]
TcAAP7 [52]
LmAAP7 [52]
Threonine One system [35]
Cysteine One system [36] One system [63]
Serine One system [77]
a T. brucei is auxotrophic for Pro [39], b TriTryps are auxotrophic for branched-chain amino acids [83–85], c TriTryps
are auxotrophic for Arg [85,86], d T. brucei and T. cruzi are auxotrophic for Orn [2,87–89], e T. cruzi is auxotrophic for
His [61,86], f TriTryps are auxotrophic for Lys [52,90,91].
3. Amino Acid Metabolism in TriTryps
3.1. Proline
Pro can be catabolized by enzymes of the tricarboxylic acid (TCA) cycle after its conversion
into Glu through two enzymatic steps [2,38,92–96]. Pro catabolism was characterized in some detail
in T. cruzi and T. brucei. It initiates via Pro dehydrogenase (PRODH, EC 1.5.99.8), which produces
pyrroline-5-carboxylate (P5C) using FAD as an electron acceptor. As previously shown for other
systems [97,98], PRODH-derived FADH2 is able to transfer electrons to the ubiquinone pool in the
electron transport chain of trypanosomes [95]. In aqueous medium, P5C is converted through a
non-enzymatic reaction to its open form glutamate-γ-semialdehyde (GSA) which is oxidized to Glu
by a P5C dehydrogenase (P5CDH, EC 1.5.1.12) with a concomitant reduction of NAD(P)+ [96,99,100]
(Figure 2).
Among the TriTryps, T. brucei was the first organism in which the first Pro oxidation step was
characterized. As described for Pro uptake, the activity of TbPRODH in PCF is downregulated
by the presence of glucose. Accordingly, in PRODH-deficient cell lines, the absence of glucose is
lethal. Even more, it was shown that Pro is the only amino acid able to sustain the growth of PCF
in a medium without glucose. In addition, the absence of glucose induces a 1000-fold increase of
oligomycin sensitivity, which is explained by the oxidative phosphorylation dependency for ATP
production when Pro is the major carbon source consumed by PCF [38]. Later, Mantilla et al. [39]
showed that the second step of Pro catabolism is also essential for PCF in glucose-depleted conditions.
Although P5CDH deficiency was not lethal in glucose-rich medium, TbP5CDH knockdown cells
showed a slower growth rate than parental cells and a diminished mitochondrial membrane potential
and capacity for ATP synthesis when cultured in medium without glucose. Remarkably, it was shown
that the integrity of the Pro–Glu pathway is important for the PCF to survive in the tsetse fly midgut,
a necessary condition for establishing infection in the tsetse vector.
The Pro–Glu pathway was also addressed in T. cruzi. It was shown that TcPRODH is a
FAD-dependent Pro oxidoreductase, which is able to reduce cytochrome c in an antimycin-sensitive
manner [95]. This enzyme is up-regulated in intracellular epimastigotes, consistent with previous
reports on its importance for differentiation of these forms to trypomastigotes [101]. P5CDH in T. cruzi
was identified and characterized as a component of the inner mitochondrial membrane. It is able to
reduce both NAD+ and NADP+, although the enzyme has a higher affinity for NAD+. TcP5CDH is
up-regulated in the infective stages (trypomastigotes and metacyclic trypomastigotes) and sustains
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energetically T. cruzi growth and the process of infecting host cells [96]. In contrast, the characterization
of Pro catabolism in Leishmania spp. has not been performed yet, although two of its steps are known
to also exist in Leishmania metabolism through genome data and by ancient and recent metabolic
studies [2,30,92,102,103].
In addition to taking it up, most of organisms can synthesize Pro de novo. The most common
biosynthesis pathway occurs from Glu through its phosphorylation to γ-glutamyl phosphate by
γ-glutamyl kinase (γGK, EC 2.7.2.11), transferring a phosphoryl group from ATP to Glu. Then,
γ-glutamyl phosphate is reduced to GSA by γ-glutamyl phosphate reductase (GPR, EC 1.2.1.41), with
the simultaneous oxidation of NADPH [104,105]. In most higher eukaryotes, γGK and GPR activities
are provided by the bifunctional enzyme P5C synthase [106,107] (P5CS, EC not assigned) and its
product, GSA, is non-enzymatically converted into P5C, which serves as a substrate for P5C reductase
(P5CR, EC 1.5.1.2) to produce Pro using NADPH or NADH as electron donors [108–111].
Figure 2. Metabolism of histidine, proline, glutamate, and glutamine. Enzymes: HAL:
histidine ammonia lyase (EC 4.3.1.3); UH: urocanate hydratase (EC 4.2.1.49); IP: imidazolone
propionase (EC 3.5.2.7); FG: formimidoylglutamase (EC 3.5.3.8); PRAC: proline racemase (EC
5.1.1.4); P5CR: pyrroline-5-carboxylate reductase (EC 1.5.1.2); P5CS: pyrroline-5-carboxylate synthase
(EC not assigned); PRODH: proline dehydrogenase (EC 1.5.99.8); P5CDH: pyrroline-5-carboxylate
dehydrogenase (EC 1.5.1.12); GDH: glutamate dehydrogenase (EC 1.4.1.3); GS: glutamine
synthetase (EC 6.3.1.2); GF6PA: glutamine fructose-6-phosphate aminotransferase (EC 2.6.1.16); CPS:
carbamoyl-phosphate synthase (EC 6.3.3.5); GMPS: GMP synthase (EC 6.3.5.2); ALAT: alanine
aminotransferase (EC 2.6.1.2); TAT: tyrosine aminotransferase (EC 2.6.1.5); GlnAT: glutamine
aminotransferase (EC 2.6.1.15). Metabolites: Pyr: pyruvate, Ala: L-alanine, XMP: xanthosine
monophosphate, Glu: L-glutamate, D-F6-P: D-fructose 6-phosphate. The question mark (?) indicates
unknown step.
Alternatively, Pro might also be produced from Orn, connecting its metabolism to Arg
metabolism through Orn aminotransferase (OAT, EC 2.6.1.13), which can provide GSA and Glu by
transferring the amino group of Orn to α-ketoglutarate (α-KG) in a pyridoxal-5-phosphate-dependent
reversible reaction [112]. However, there is as yet no biochemical evidence for the OAT enzyme in
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trypanosomatids, nor has a putative gene encoding such an enzyme been detected [20], and the urea
cycle is not operative in these protists [102,113].
T. brucei is auxotrophic for Pro [39], whereas T. cruzi is capable of producing Pro in its cytosol
from Glu via P5CS and P5CR. Interestingly, this Pro production in T. cruzi is NADPH-dependent
and is regulated by the cytosolic pools of this cofactor (Marchese et al., unpublished data). Little is
known about Pro biosynthesis in Leishmania spp., but it should be remarked that their genomes
contain candidate genes for P5CS and P5CR [2,102]. In addition, Pro was not essential for growth
of promastigotes in NM defined medium, strongly indicating that the biosynthetic pathway for this
amino acid can be operative in these Leishmania [85].
Like some bacteria, the trypanosome species T. cruzi and T. vivax can interconvert L- and D-Pro
through a Pro racemase (PRAC, EC 5.1.1.4) [58,114]. The first eukaryotic PRAC was identified as
secreted in the culture medium by T. cruzi [115]. The T. cruzi genome encodes two isoforms of TcPRACs
with different kinetic properties, one secreted, and one remaining intracellularly [116,117]. The role of
D-Pro, and the interconversion between L- and D-Pro by the TcPRAC have not yet been completely
elucidated, although there are some clues about the role of the enzyme in different aspects of the
biology of T. cruzi, as will be discussed later in this review.
3.2. Glutamine, Histidine, and Glutamate
Glu can be considered a metabolic hub, which can be produced from a variety of metabolic sources
(such as His, Gln, Pro, or the TCA cycle intermediate α-KG). In addition, it can be a precursor for these
metabolites in most cells. Once Glu is available inside the cells, it can be reversibly converted into α-KG
by the enzyme Glu dehydrogenase (GDH, EC 1.4.1.3) [118,119], transferring the amino group to H2O
(forming NH4+), thus participating in energy metabolism [93,120]. Moreover, α-KG can be converted
into malate, and further into pyruvate through the malic enzymes [121]. Alternatively, the amino
group can be removed from Glu to be transferred to pyruvate by an Ala aminotransferase (ALAT,
EC 2.6.1.2) or a Tyr aminotransferase (TAT, EC. 2.6.1.5) generating Ala and α-KG, respectively [122].
Remarkably, α-KG can be aminated to produce Glu, a mechanism to detoxify the excess of NH4+
produced by amino acid consumption. As mentioned, the amino group can be transferred to pyruvate
or other keto-acids serving as substrates for the ALAT or TAT, to allow the recovery of α-KG, critical
for keeping the TCA cycle working (Figure 2).
Glu is also produced through the catabolism of other amino acids, such as Pro (as described
above), His, and Gln. His can be converted into Glu through a four-enzymatic-steps degradation
pathway [61]. The first step of His catabolism involves the formation of urocanate and NH4+ catalyzed
by His ammonia lyase (HAL, EC 4.3.1.3). Next, urocanate hydratase (UH, EC 4.2.49) converts urocanate
in 4-imidazolone-5-propianate (IPA) that is hydrolyzed by imidazolone propionase (IP, EC 3.5.2.7)
resulting in N-formimine-L-glutamate. The last step involves the formation of Glu and formamide
through a formimidoylglutamase (FG, EC 3.5.3.8) (Figure 2).
According to the TriTryp genome database, T. cruzi is the only trypanosomatid containing genes
for the four-step pathway converting His into Glu. This is in agreement with the capacity of T. cruzi
to completely oxidize His, forming CO2 [61]. Transcriptomic data have shown that the first two
enzymes of the His degradation pathway are primarily expressed in the invertebrate host stages [123].
Accordingly, an increase of the levels of urocanate, the product of the first step of His degradation, has
been reported for stationary phase epimastigotes [124].
The availability of Gln depends on its uptake from the culture medium (Damasceno et al.,
unpublished data) and its biosynthesis catalyzed by Gln synthetase (GS, EC 6.3.1.2), which uses Glu
and NH4+ as precursors, in a reaction that requires ATP. Incidentally, GS activity participates in the
NH4+ detoxification and, probably through the resulting control of the low pH, in the parasite exit
from the parasitophorous vacuole inside the host [125].
Gln can participate as nitrogen donor in the hexosamine pathway by the enzyme Gln
fructose-6-phosphate aminotransferase (GF6PA, EC 2.6.1.16) (our unpublished data), as well as in
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the pyrimidine biosynthesis by the enzyme carbamoyl-phosphate synthase [126,127] (CPS EC 6.3.3.5)
and in the GMP synthesis through the action of the enzyme GMP synthase [128] (GMPS, EC 6.3.5.2).
Moreover, Gln is a substrate for the enzyme Gln aminotransferase (GlnAT, EC 2.6.1.15) that transfers
the amino group from Gln to pyruvate, generating Ala and α-ketoglutaramate [129].
Leishmania can take Glu up from the culture medium [76] and oxidize it intracellularly by the
TCA cycle, thus contributing to the energy metabolism [102]. Additionally, in Leishmania spp., Glu
can be converted into Gln by a GS [130], as occurs in T. cruzi, using Glu and NH4+ as substrates.
Moreover, the importance of the enzyme GF6PA (which uses Gln as substrate, and participates in the
hexosamine pathway) was demonstrated. Promastigote GF6PA null mutants are unable to proliferate
inside macrophages [131].
3.3. Arginine and Ornithine
Arg forms, in most eukaryotes, one of the central metabolic nodes, connecting the urea cycle
with Glu/Pro metabolism through its conversion to Orn by an arginase (ARG, EC 3.5.3.1) and then to
GSA/P5C by OAT. As explained above, the oxidation of P5C by P5CDH yields Glu, which connects
with the TCA cycle through α-KG. This makes it crucial for cell viability since it is a precursor of Orn,
urea, NO, polyamines (see below), and other amino acids, such as Pro [132]. When arginase is present,
a major metabolic fate of Arg is the synthesis of polyamines. It happens through a complex pathway
that involves four steps. First, Arg is converted into Orn through the action of an arginase (ARG, EC
3.5.3.1). Orn is then decarboxylated in a reaction catalyzed by Orn decarboxylase (ODC, EC 4.1.1.17),
generating putrescine. Next, spermidine synthase (SPDS, EC 2.5.1.16) adds an aminopropyl group to
putrescine, finally generating spermidine. The last step uses a decarboxylated S-adenosylmethionine
as an aminopropyl donor, which is an outcome of the action of the enzyme S-adenosylmethionine
decarboxylase (AdoMetDC, EC 4.1.1.50). In mammals, there is a fifth step in which spermidine is
converted to spermine [133].
Interestingly, in T. brucei and Leishmania spp. this latter step is not present, while T. cruzi, in turn,
seems to have lost the ODC coding sequence and is auxotroph for diamines [134]. In trypanosomatids,
spermidine can be used to synthesize the redox agent trypanothione, which is specific to these
organisms [135]. This synthesis occurs through a two-step pathway mediated by a single enzyme,
the trypanothione synthetase (TRYPSY, EC 6.3.1.9) [136–138]. Trypanothione, in turn, can be reduced
by the homolog of glutathione reductase, the trypanothione reductase (TRYPRD, EC 1.8.1.12) [139,140]
(Figure 3).
In Leishmania spp. the catabolism of Arg involves its conversion to Orn and urea, catalyzed by
ARG. LmARG is compartmentalized in peroxisome-related organelles, named glycosomes [141,142],
differently from its mammalian counterparts, in which one isoform is present in the cytosol and
the other one in mitochondria [143]. The other enzymes involved to polyamine biosynthesis are
cytosolic. Therefore, Arg seems to be taken up from the extracellular medium, converted into
Orn within glycosomes, after which Orn goes back to the cytosol where it becomes a precursor
in polyamine biosynthesis. However, when LmARG is expressed without its glycosomal-targeting
signal, it localizes as an active enzyme to the cytosol where it is able to restore the synthesis of
polyamines in ARG-knockout cell lines of L. mexicana promastigotes [141]. In L. major and L. tropica,
expression and enzymatic activity of LmARG were found to be higher in promastigote cells during
their logarithmic growth than in the stationary phase [144]. Promastigotes of L. mexicana and
L. donovani ARG-null mutants are auxotrophic for polyamines and require supplementation of Orn or
putrescine to grow. However, deletion of ARG had no effect on amastigotes proliferation in spleens
of infected mice [141,145]. Interestingly, transcriptomics and metabolomics analyses of promastigote
and amastigote ARG-null mutants revealed a tight regulation of the expression of genes associated
with Pro and polyamine metabolism, as well as the levels of metabolites associated with this pathway.
These results strongly suggest a metabolic regulon controlled by ARG expression [82].
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T. cruzi and T. brucei use Arg in different ways than Leishmania spp. In the case of T. brucei,
a metabolomics analysis of BSF showed the lack of ARG activity [88]. Additionally, the only gene
encoding a putative ARG encodes an enzymatically non-functional version of ARG [146], pointing to
the absence of a canonical mechanism to produce Orn from Arg. This fact would explain the relevance
of Orn uptake by AAT10-1 and AAT2-4 in this parasite [46]. Interestingly, it has been shown that
both parasites possess an Arg kinase (ArgK, EC 2.7.3.3) that can reversibly phosphorylate Arg to
phospho-Arg (P-Arg) using ATP. P-Arg contributes to the management of the energetic metabolism
in these parasites, acting like an energy backup when restoration of ATP levels is needed [51,147].
Furthermore, by measuring Arg uptake and the expression and activity levels of ArgK in different
life-cycle stages, a connection between Arg metabolism and cell proliferation has been proposed for
T. cruzi [148,149]. In T. brucei there are three isoforms of ArgK, being localized in the flagellum (TbAK1),
the mitochondrion (TbAK2), and the cytosol (TbAK3). Although all isoforms are expressed throughout
the life cycle of these parasites, higher ArgK activities have been detected in the BSF, suggesting a
major role of P-Arg in the energy metabolism of this life-cycle stage [150]. More recently, it has been
shown that the flagellar isoform of ArgK is essential for T. brucei infectivity of the tsetse fly, although
the exact mechanism still remains to be elucidated [151].
Figure 3. Metabolism of arginine and ornithine. Enzymes: ArgK: arginine kinase (EC 2.7.3.3);
ARG: arginase (EC 3.5.3.1); ODC: ornithine decarboxylase (EC 4.1.1.17); SPDS: spermidine synthase
(EC 2.5.1.16); SMS: spermine synthase (EC 2.5.1.2); TRYPSY: trypanothione synthase (EC 6.3.1.9).
Metabolite: DecAdoMet: decarboxylated S-adenosyl methionine.
3.4. Branched-Chain Amino Acids
Ile, Leu, and Val, the BCAA are biosynthesized only by plants and fungi among the eukaryotic
organisms [83,84]. Indeed, there is evidence that BCAA are also essential in the TriTryp parasites.
However, they seem to be able to catabolize them all [85,89,152–154]. The catabolic pathway of BCAA
involves several enzymatic steps, some in common for all three amino acids and others specific for
some of them. The first enzymatic reaction consists of the deamination of the BCAA producing the
derived 2-oxo acid of the corresponding amino acid: α-ketoisocaproic acid, α-keto-β-methylvaleric
acid, and α-ketoisovaleric acid are produced from Leu, Ile, and Val, respectively. Usually, in
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eukaryotes this deamination is catalyzed by specific dehydrogenases, producing NH3/NH4+ (ValDH,
EC 1.4.1.8; LeuDH, EC 1.4.1.9) [155,156] or by branched-chain aminotransferases (BCATs, EC 2.6.1.42),
pyridoxal phosphate-dependent enzymes that usually use α-KG as the acceptor for the amino group
(leading to the formation of Glu) [157,158]. The BCATs might be located in the cytosol and the
mitochondrion. The following enzymatic step is performed by a mitochondrial dehydrogenase
complex, named branched-chain α-keto-acid dehydrogenase complex (BCKDC), which is constituted
by three enzymes: E1, E2, and E3 (EC 1.2.4.4; EC 2.3.1.168; EC 1.8.1.14, respectively) [83]. The complex
catalyzes the oxidative and irreversible decarboxylation of the three BCKDC, producing the acetyl-CoA
derivatives isovaleryl-CoA, 3-methylbutyryl-CoA, and isobutyryl-CoA, and also NADH and CO2.
Remarkably, all these products can be substrates of acyl-CoA dehydrogenases (ACADs, EC 1.3.8.7)
as happens with the acyl-CoA derived from the β-oxidation of fatty acids in the mitochondrial
matrix [159–161]. From this step forward, the pathways resemble some of those of fatty-acid oxidation,
resulting in end products that can be introduced into the TCA cycle. The complete oxidation of
Leu generates acetoacetate and acetyl-CoA (both ketogenic compounds), Val generates succinyl-CoA
(glucogenic), and Ile produces propionyl-CoA and acetyl-CoA (glucogenic and ketogenic compounds,
respectively) [83] (Figure 4).
Figure 4. Metabolism of BCAAs. Enzymes: BCATs: branched-chain aminotransferases (EC 2.6.1.42);
BCKDC: branched-chain α-keto acid dehydrogenase complex (E1: EC 1.2.4.4; E2: EC 2.3.1.168 and E3:
EC 1.8.1.4); ACADs: acyl-CoA dehydrogenases (EC 1.3.8.7). Metabolites: α-KG: α-ketoglutarate, Glu:
L-glutamate, CoA: coenzyme A.
The first studies on BCAA catabolism in TriTryps were performed on T. cruzi and L. donovani,
demonstrating that the insect forms are able to metabolize Leu through the TCA cycle [162,163]. Leu is
the most studied BCAA in TriTryps, since it has been described as a precursor of sterol and fatty-acid
biosynthesis in Leishmania spp., T. cruzi, and T. brucei, although the latter species prefers acetate as a
precursor [164–167]. Noteworthy, glucose and Thr are also main carbon sources used by T. brucei PCF
for acetyl-CoA and lipid biosynthesis [94,168,169].
BCAT genes have been predicted in T. brucei and Leishmania spp. genomes [20]. Surprisingly, the T.
cruzi genome lacks a putative BCAT gene, although T. cruzi epimastigotes are able to fully oxidize
BCAA [170]. This dilemma was recently solved by showing the unusual BCAT activity displayed by
the T. cruzi TAT and ALAT [171]. Putative genes encoding BCKDC and ACAD are also present in the
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TriTryp genome database, which were recently characterized in our laboratory (Manchola, N. C. et al.,
Ornitz, O. O. S. et al., unpublished data).
3.5. Asparagine and Aspartate
As mentioned above, Asp is transported into T. cruzi epimastigote and trypomastigote cells [59]
and is important for the metacyclogenesis process [172]. Moreover, Asp is converted to oxaloacetate by
the enzyme aspartate aminotransferase [118] (ASAT, EC 2.6.1.1), and participates in ATP production
through the TCA cycle and subsequent oxidative phosphorylation [93]. T. cruzi and T. brucei present
two isoforms of the enzyme Asp aminotransferase, one being cytosolic (cASAT) and the other
one mitochondrial (mASAT). In T. brucei, the cASAT is constitutively expressed and mASAT is
down-regulated in BSF, whereas in T. cuzi the mASAT is expressed along the whole life cycle and the
cASAT is specifically expressed during the mammalian stages [173,174]. Asp can also be synthesized
from the TCA cycle intermediate oxaloacetate and by deamination of Asn (Figure 5).
Figure 5. Metabolism of asparagine, aspartate and alanine. Enzymes: AS: asparagine synthetase
(EC 6.3.1.1); ASN: asparaginase (EC 3.5.1.1); AdesS: adenylosuccinate synthetase (EC 6.3.4.4); ACT:
aspartate carbamoyl transferase (EC 2.1.3.2); ASAT: aspartate aminotransferase (EC 2.6.1.1); ALAT:
alanine aminotransferase (EC 2.6.1.2); TAT: tyrosine aminotransferase (EC 2.6.1.5); AlaR: alanine
racemase (EC 5.1.1.1). Metabolites: α-KG: α-ketoglutarate, Glu: L-glutamate, Gln: L-glutamine.
It has been shown that, in T. brucei BSF, Asp is a precursor of pyrimidine biosynthesis through the
enzymes Asp carbamoyl transferase (ACT, EC 2.1.3.2) and adenylosuccinate synthetase [175] (AdesS,
EC 6.3.4.4). Asp can also be converted into Asn by the enzyme Asp ammonia ligase (EC 6.3.1.1) which
catalyzes the formation of Asn from Asp and NH4+, or Asn synthetase (AS, EC 6.3.1.1), that could use
either NH4+ or Gln (EC 6.3.5.4) as nitrogen donors, both reactions being ATP-dependent. Additionally,
this parasite becomes auxotrophic for Asn when AS expression is knocked down [176].
Leishmania is able to synthesize both Asp and Asn from oxaloacetate by a mitochondrial ASAT
and an AS [102]. Asp can support growth and Asn is non-essential when the parasites are cultivated
in the presence of glucose [85]. Similarly as to what occurs in T. cruzi and T. brucei, Leishmania also has
an active AS which can use NH4+ or Gln as nitrogen donors. This enzyme is not essential for parasite
growth, infectivity, or survival in normal cultivation conditions [177]. More recently, an asparaginase
(ASN, EC 3.5.1.1) has been characterized in Leishmania. This enzyme converts Asn into Asp and
ammonia [178]. ASN was also demonstrated to be involved in conferring resistance to the drug
amphotericin B in both amastigote and promastigote forms grown in axenic conditions [179].
3.6. Cysteine and Methionine
Met metabolism is involved in the biosynthesis of Cys, phospholipids, and polyamines [173,180].
Catabolism and biosynthesis of Met are connected by two regeneration cycles. The first catabolic
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step is common to both Met regeneration cycles: it produces S-adenosylmethionine (AdoMet)
from Met and ATP by S-adenosylmethionine synthetase (AdoMetS, EC 2.5.1.6), also named Met
adenosyltransferase. From this point, AdoMet can be a methyl donor for several methyltransferases,
or it can be decarboxylated. Despite the large variety of specific methyltransferases (MTs,
EC 2.1.1.-), such as Cys 5-methytransferase (CMT, EC 2.1.1.37), the major common byproduct
is S-adenosylhomocysteine [180,181] (AdoHcys). From AdoHcys formation, the catabolism
of Met can generate propionyl-CoA (a precursor of succinyl-CoA) via the degradation to
α-ketobutyrate (α-KB) [182,183], through five enzymatic steps. The last three steps are performed
by S-adenosylhomocysteine hydrolase (AdoHcysHD, EC 3.3.1.1), cystathionine β-synthase (CBS,
EC 4.2.1.22), and cystathionine γ-lyase (CGL, EC 4.4.1.1), producing, respectively, homocysteine,
cystathionine, and α-KB together with Cys. One of the Met regeneration cycles is completed by the
conversion of homocysteine to Met by four enzymes, i.e., betaine-homocysteine S-methyltransferase
(BHMT, EC 2.1.1.5), homocysteine S-methyltransferase (HMT, EC 2.1.1.10), and either Met
synthase (MetH, EC 2.1.1.13) or cobalamin-independent Met synthase [180,184] (MetE, EC 2.1.1.14).
Homocysteine itself can be catabolized by homocysteine desulfurase (HD, EC 4.4.1.2), forming sulfide,
α-KB, and NH4+ [185] (Figure 6).
Figure 6. Metabolism of methionine and cysteine. Enzymes: AdoMetS: S-adenosylmethionine
synthetase (EC 2.5.1.6); MTs: methyltransferases (EC 2.1.1.-); AdoHcysHD: S-adenosylhomocysteine
hydrolase (EC 3.3.1.1); CBS: cystathionine β-synthase (EC 4.2.1.22); CBL: cystathionine β-lyase (EC
4.4.1.8); CGL: cystathionine G-lyase (EC 4.4.1.1); CGS: cystathionine G-synthase (EC 2.5.1.48); BHMT:
betaine-homocysteine S-methyltransferase (EC 2.1.1.5); HMT: homocysteine S-methyltransferase
(EC 2.1.1.10); MetH: methionine synthase (EC 2.1.1.13); MetE: methionine synthase (EC 2.1.1.14);
AdoMetDC: AdoMet decarboxylase (EC 4.1.1.50); SPDS: spermidine synthase (EC 2.5.1.16); SMS
spermine synthase (EC 2.5.1.22); MTAP: 5-methylthioadenosine phosphorylase (EC 2.4.2.28); MTAPi:
5-methylthioribose 1-phosphate isomerase (EC 5.3.1.23); MTAN: 5-methylthioadenosine nucleosidase
(EC 3.2.2.16); MTRK: 5-methylthioribose kinase (EC 2.7.1.100); ASAT: aspartate aminotransferase
(EC 2.6.1.1); MGL: methionine G-lyase (EC 4.4.1.11); MSR: methionine sulfoxide reductase (EC
1.8.4.13/1.8.4.14); CD: cysteine disulfurase (EC 2.8.1.7); CS: cysteine synthase (EC 2.5.1.47); SAT:
serine acetyltransferase (EC 2.3.1.30); HD: homocysteine desulfurase (EC 4.4.1.2). Metabolites: α-KB:
α-ketobutyrate, Ser: L-serine. Question mark (?) indicates unknown step.
As already mentioned, AdoMet can also undergo decarboxylation, initiating the other
Met regeneration cycle [185,186]. This decarboxylation is performed by AdoMetDC producing
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decarboxylated AdoMet (DecAdoMet), which is an aminopropyl donor in the polyamine
biosynthesis [187]. In mammals, this catalytic step is rate-limiting in the polyamine formation [188].
The aminopropyl moiety can be transferred to putrescine or spermidine yielding, respectively,
spermidine or spermine by SPDS or SMS [180]. The reactions catalyzed by the latter two enzymes
also produce 5-methyl thioadenosine, which is converted directly to 5-methylthioribose 1-phosphate
by 5-methylthioadenosine phosphorylase (MTAP, EC 2.4.2.28), or through two steps performed by
5-methylthioadenosine nucleosidase (MTAN, EC 3.2.2.16) and 5-methylthioribose kinase (MTRK, EC
2.7.1.100). Next, 5-methylthioribulose 1-phosphate is formed from 5-methylthioribose 1-phosphate by
5-methylthioribose 1-phosphate isomerase (MTAPi, EC 5.3.1.23). Two more steps lead to the production
of α-ketomethiobutyrate (KMTB); the intermediates have been identified, but the enzymes/reaction
mechanisms involved have not yet been fully elucidated [185]. Finally, the regeneration of Met from
KMTB occurs through the activity of an aromatic amino acid transaminase [189]. In addition, Met
can be catabolized to methanethiol and α-KB by Met γ-lyase (MGL, EC 4.4.1.11) [185,186] and to Met
sulfoxide (MetSO) by Met sulfoxide reductases (MSRs): Met (S)-S-oxide reductase (MSR-A, EC 1.8.4.13)
and Met (R)-S-oxide reductase (MSR-B, EC 1.8.4.14), which produce two enantiomers, R-MetO and
S-MetO, respectively [190] (Figure 6).
The first step of Met catabolism has been extensively studied in L. infantum. AdoMetS activity
was measured in promastigotes and shown to be higher in lag and early-log phases of growth [191].
The genomic DNA of the parasite has two identical genes encoding AdoMetS. Through kinetic studies
made with the heterologously-expressed enzyme it was shown that it was insensitive to the expected
allosteric inhibition by AdoMet [192]. Two other enzymatic steps in Met metabolism were also studied
in Leishmania spp.: (i) the decarboxylation of AdoMet, and (ii) the Met oxidation. The decarboxylation
of AdoMet is performed by an AdoMetDC. In Leishmania spp., one gene encoding this enzyme was
found, but, additionally, a copy annotated as a putative AdoMetDC-like proenzyme (AdoMetDCL)
could be found, as in other trypanosomatids [193–195]. In L. donovani the knockout of the AdoMetDC
gene led to spermidine auxotrophy [196]. In addition, structural and functional characterization of
AdoMetDCL in L. donovani was performed, evidencing that it binds AdoMet and putrescine and may
play an essential role in polyamine biosynthesis [195]. The oxidation of Met is performed by a MRS-A.
This enzyme has been characterized in L. major where the genome encodes one functional copy for the
cytosolically located LmMRS-A. Parasites knocked out for LmMRS-A exhibited increased sensitivity to
H2O2. However, this protein is not essential for pathogenesis in vivo [197].
Initially, in BSF of T. b. brucei, different Met catabolic enzymes were identified:
activities of AdoMetDC [198], AdoMetS, AdoHcysHD, CBS, and several MTs (guanidinoacetate
N-methyltransferase-GAMT, EC 2.1.1.2; Gly N-methyltransferase-GNMT, EC 2.1.1.20; HMT; and
MetH) were described. Yarlett and Bacchi also demonstrated that the AdoMet concentration is 50-fold
higher in BSF isolated from rats treated with DFMO than from untreated rats [199]. Subsequently,
the kinetic characterization of AdoMetS activity was performed in these parasites, evidencing
the presence of two isoforms and a weak inhibition by the AdoMet product when compared
to the corresponding mammalian enzyme [200]. Another study by Bacchi and coworkers [201]
showed that these parasites are able to metabolize Met into intermediates of the polyamine and
methyltransferases pathways. The AdoMetDC activity was initially described as being insensitive
to putrescine and Mg2+ [198]. However, Tekwani et al. [202] showed a strong activation by
putrescine when cell-free extracts were dialyzed, similarly as to what occurs with AdoMetDC from
mammalian cells. Like other trypanosomatids, T. brucei has a gene encoding an active AdoMetDC
and a catalytically-inactive version of AdoMetCD (“prozyme”) which is able to form a high-affinity
heterodimer stimulating the AdoMetDC activity [193,203]. In T. brucei the next (and last) metabolic
step after AdoMet decarboxylation can be performed by the ASAT, which also has catalytic activity of
an ALAT [173,174,189].
Met oxidation was also investigated in T. brucei: cloning, bacterial expression, and characterization
of a MSR-A has been reported that is expressed in both BSF and PCF stages [204]. Recently, two more
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MSRs from T. brucei were characterized, a cytosolic one homologous to the MSR-A family, and a
mitochondrial one, with sequence motifs typical of MSR-Bs. Interestingly, a reduced expression of
TbMSR-A gave rise to an increased susceptibility to exogenous H2O2, while elevated expression levels
resulted in more resistance to oxidative imbalance [205].
In T. cruzi, the first study of Met metabolism reported the cloning of putative genes of
AdoMetDC and AdoHcysHD, as well as the expression and kinetic characterization of their proteic
products [206,207]. Like in T. brucei, TcAdoMetDC is stimulated by putrescine [206] and by a
prozyme [203]. Still in the same way as in T. brucei, the cytosolic TcASAT regenerates Met from
KMTB [174]. Lastly, two genes encoding TcMSR-As were cloned and the proteins expressed and
characterized. The MSR-A activity was also detected in cytosolic extracts of replicative stages
(epimastigotes and amastigotes). Furthermore, the overexpression of one of the isoforms in
epimastigotes increased the resistance of these cells to oxidative imbalance generated by exogenous
H2O2 [204].
Beyond its role as a sulfur group-containing building block for proteins, Cys is crucial for the
biosynthesis of the reducing agent trypanothione in trypanosomatids. In fact, Cys has been shown to
be essential for cell viability in BSF T. brucei and addition of this amino acid to the culture medium
enabled, axenically, culture of this life-cycle stage [36,208,209]. In contrast, L. major and L. mexicana
promastigotes are able to grow in the absence of Cys [85,210], suggesting that a Cys biosynthesis
pathway probably exists in these organisms.
As mentioned above, Cys can be synthesized by using Met as a precursor via the reverse
transsulfuration pathway. This pathway involves the enzymes CBS and CGL. Alternatively, Cys
biosynthesis can also be achieved via Ser acetyltransferase (SAT, EC 2.3.1.30) which catalyzes the
conversion of Ser to O-acetylserine (OAS) and Cys synthase [211] (CS, EC 2.5.1.47) (Figure 6),
which catalyzes the addition of a sulfide group to O-acetylserine (OAS). T. cruzi and L. major seem to
be the only unicellular organisms studied to date that contain both active pathways and the biological
relevance of this redundancy for Cys biosynthesis remains to be elucidated. The characterization of
these pathways in T. cruzi has shown that CBS has a higher activity in epimastigotes, whereas CS is
active both in epimastigotes and amastigotes. Regarding their expression, both CBS and CGL have
been shown to be more expressed in the insect-stage epimastigote whilst CS is more abundant in the
mammalian-stage amastigote, suggesting a developmental regulation of the reverse transsulfuration
pathway in this organism [212,213]. Noticeably, the genome of T. brucei contains putative coding
sequences only for CBS and CGL, but the reverse transsulfuration pathway remains uncharacterized
in this organism.
In L. braziliensis amastigotes, CS levels and activity were increased together with CBS and CGL,
whereas CBS is more active in promastigotes. The overexpression of either CBS or CS in L. braziliensis
promastigotes increased the resistance of these parasites to oxidative imbalance, in agreement with the
role of Cys as an anti-oxidant and its participation as a precursor of trypanothione biosynthesis [214].
CGL was also characterized in L. major and L. mexicana, where it was shown to have a cytosolic
localization in promastigotes [215]. SAT and CS are also present in the cytosol, forming a complex that
would have an increased activity compared to the individual enzymes, as suggested by in vitro studies
in which L. major and L. donovani CS stimulate their respective SAT activities [179,210,216], similarly as
previously observed in plants [217].
Cys can be also catabolized through the action of Cys desulfhydrase (CD, EC 2.8.1.7),
which converts Cys into H2S, NH3, and pyruvate. This enzyme has only been characterized in
L. major, being able to specifically use Cys as a substrate [216]. Cys can also be converted back to Met
via cystathionine β-lyase (CBL, EC 4.4.1.8) and cystathionine γ-synthase (CGS, EC 2.5.1.48) but, to
date, this pathway has not been characterized in any of the trypanosomatids.
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3.7. Other Amino Acids: Phenylalanine, Tryptophan, Tyrosine, Serine, Glycine, Threonine, Alanine, and Lysine
3.7.1. Aromatic Amino Acids (Phe, Trp and Tyr)
Trypanosomatids are auxotrophic for aromatic amino acids and depend on their uptake from
the extracellular environment [85,91]. Once imported, these amino acids are metabolized in aromatic
acids by pathways that vary among these organisms. T. cruzi has two enzymes involved in the
catabolism of aromatic amino acids: TcTAT that produces α-oxoacids, and an aromatic L-2 hydroxyacid
dehydrogenase (TcAHADH, EC 1.1.1.337) that converts α-oxoacids into α-hydroxyacids using
NADH [218,219] (Figure 7). TcTAT is only expressed in epimastigotes, where it can transaminate Phe,
Trp, and Tyr, as well as Ala, Leu, Ile, Val, Glu, and Met using pyridoxal phosphate (PLP) as a cofactor,
with a preference for Tyr [171,218,220–222]. Not much is known about TcAHADH, which belongs to
the malate dehydrogenases family, although it does not have any MDH activity [223].
Figure 7. Metabolism of tyrosine, tryptophan and phenylalanine. Enzymes: PAH: phenylalanine
hydroxylase (EC 1.14.16.1); TAT: tyrosine aminotransferase (EC 2.6.1.5); ASAT: aspartate
aminotransferase (EC 2.6.1.1); AHADH: aromatic L-2-hydroxyacid dehydrogenase (EC 1.1.1.337).
Metabolites: α-KG: α-ketoglutarate, Glu: L-glutamate, H4B: Tetrahydrobiopterin, H2B:
Dihydrobiopterin. Question mark (?) indicates unknown step (adapted from [224]).
In L. donovani, transaminases are active, having most amino acids as amino group donors and
both α-KG and pyruvate as preferred acceptor co-substrates [225,226]. In addition, a broad-specificity
aminotransferase (BSAT, EC 2.6.1.1) has been identified, able to transaminate all aromatic amino acids,
as well as Asp, Met, Leu and, with a lower activity, Ala in L. mexicana [227,228]. Similarly to T. cruzi,
Leishmania spp. also have a TAT, which is able to transaminate aromatic amino acids and Met using
pyruvate as an amino group acceptor. However, it does not have ALAT activity [129]. There is no
AHADH in Leishmania spp. in agreement with the absence of aromatic products excreted in culture
media [224,228]. Finally, Leishmania contains a Phe hydroxylase (PAH, EC 1.14.16.1) that can convert
Phe into Tyr using tetrahydrofolate as a co-substrate [229].
In T. brucei, conversion of Phe into phenylpyruvate, as well as Tyr into p-hydroxyphenylpyruvate
and p-hydroxyphenyllactate, the latter reaction being NADH-dependent, has been demonstrated.
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Indoleacetate, indolepyruvate, and tryptophol have been detected as products of Trp
catabolism [230–232]. Additionally, several studies reported that products of aromatic amino-acid
metabolism were increased in urine and blood of animals infected with T. b. gambiense and T. b.
evansi [233–235]. Furthermore, it has been demonstrated that indolepyruvate can modulate the
immune response in infected mice [236], which points to a role for aromatic amino acids in the
successful establishment of an infection by T. brucei.
So far, no homolog of TAT has been found in T. brucei. Instead, it has been recently shown that
the aromatic ketoacids resulting from Phe, Tyr, and Trp metabolism are products of the activity of
the cytosolic ASAT in BSF T. brucei [174]. Furthermore, aromatic amino acids play an important role
in Met recycling, where they act as the major amino group donor to α-ketomethiobutyrate to yield
Met [173,189].
3.7.2. Glycine and Serine
Both Ser and Gly metabolic pathways can contribute to folate metabolism, as well as to Cys
and Met synthesis. In the former process, tetrahydrofolate (THF) is used as a co-substrate in a
reversible reaction with Ser catalyzed by Ser hydroxymethyltransferase (SHMT, EC 2.1.2.1) resulting in
5,10-methylene tetrahydrofolate (5,10-MTHF) and Gly [237]. 5,10-MTHF is an important precursor in
the thymidylate and Met synthesis, and it can also be synthesized in the mitochondrion from Gly and
THF through the action of the Gly cleavage complex (GCC) [238] (Figure 8).
Figure 8. Metabolism of serine, glycine and threonine. Enzymes: CBS: cystathionine β-synthase
(EC 4.2.1.22); SAT: serine acetyltransferase (EC 2.3.1.30); SHMT: serine hydroxymethyltransferase
(EC 2.1.2.1]; TDH: threonine dehydrogenase (EC 1.1.1.406]; ThrS: threonine synthase (EC 4.2.3.1);
HSK: homoserine kinase (EC 2.7.1.39); AKCT: 2-amino-3-ketobutyrate CoA-transferase (EC 2.3.1.29);
GCC-P: glycine decarboxylase (EC 1.4.4.2); GCC-T: tetrahydrofolate aminomethyltransferase (EC
2.1.2.10); GCC-L: dihydrolipoamide dehydrogenase (EC 1.8.1.4). Metabolites: A-CoA: acetyl coenzyme
A, CoA: coenzyme A, THF: tetrahydrofolate, 5,10-MTHF: 5-10-methylene tetrahydrofolate.
The first evidence that Ser could be metabolized in trypanosomatids was provided by Hampton,
when analyzing the incorporation of radioactivity from both uniformly-labeled Ser and Ser-1-14C.
Labeled carbons were incorporated in all fractions except nucleic acids. In addition, a large production
of radio-labeled CO2 was detected when T. cruzi epimastigotes were incubated with Ser-1-14C [47].
Cys, Ala, Gly, as well as Glu and Asp, can also be products of Ser metabolism [239]. Later, SHMT
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activity was demonstrated in T. cruzi, Trypanosoma rangeli and Leishmania spp., with T. cruzi having the
highest activity of this enzyme [240].
Two isoforms of SHMT have been characterized in Leishmania, one being cytosolic and the other
one mitochondrial [241]. In the presence of Ser, both isoforms have been shown to be dispensable for
cell growth in L. major. However, gene knock-out of one or both of the SHMT isoforms is lethal in the
absence of Ser [242].
The T. cruzi genome contains a single SHMT gene, which encodes the cytosolic isoform and uses
pyridoxal phosphate (PLP) as a cofactor [243]. In contrast, no SHMT gene is present in the T. brucei
genome, which suggests that T. brucei depends only on GCC to synthesize 5,10-MTHF.
GCC is a complex formed by four subunits: a Gly decarboxylase that is known as P-protein
(GCC-P, EC 1.4.4.2), a tetrahydrofolate aminomethyltransferase known as Gly synthase or T-protein
(GCC-T, EC 2.1.2.10), a dihydrolipoamide dehydrogenase known as L-protein (GCC-L, EC 1.8.1.4),
and an H-protein which contains a lipoamide prosthetic group. There are putative homologs for the
four subunits of the complex encoded in the L. major, T. brucei, and T. cruzi genomes. In Leishmania
spp., subunit P is localized in the mitochondrion and its knockout in amastigotes caused a delay in the
progress of an infection in mice [244]. In T. brucei and T. cruzi, L-protein is the best-characterized GCC
subunit and it catalyzes the formation of 5,10-MTHF in a NAD-dependent reaction. In T. brucei this
enzyme is localized in the mitochondrion and, accordingly, it is more expressed in the procyclic form.
However, the L-protein has been shown to be essential in both insect and mammalian stages of the
parasite [245–249]. In T. cruzi this enzyme has been investigated as a potential drug target since it is
inactivated by free radicals derived from phenol and its mRNA is up-regulated in cell lines resistant to
benznidazole [250–253].
3.7.3. Threonine
In T. brucei PCF, Thr is the most-consumed amino acid regardless of the growth conditions, with
a consumption rate comparable to that of glucose [38,254]. However, Thr cannot sustain growth
of the parasite in vitro since it is converted into other metabolites, including the excreted acetate
and Gly end products, which are not or poorly used for energy production in trypanosomatids [38].
Thr is first reduced by Thr dehydrogenase (TDH, EC 1.1.1.103) into amino-oxobutyrate, which is
converted into acetyl-CoA and Gly by 2-amino-3-ketobutyrate CoA-transferase (AKCT, EC 2.3.1.29).
Then, acetyl-CoA is converted into acetate by acetate:succinate CoA-transferase (ASCT, EC 2.8.3.8),
or acetyl-CoA thioesterase [168,255] (ACH, EC 3.1.2.3). In in vitro conditions, Thr, via acetyl-CoA, is
the preferred source of carbon for fatty-acid and sterol synthesis [169,256]. Interestingly, expression of
TDH is down-regulated in a phosphoenolpyruvate carboxykinase (PEPCK) null background probably
as a consequence of the redirection of the metabolic flux towards acetate production, suggesting that a
metabolite of this latter pathway participates in the control [169] (Figure 8).
Leishmania spp. and T. cruzi genomes do not contain genes encoding enzymes for the Thr
degradation pathway, suggesting that these parasites are not able to catabolize this amino acid [169].
This is consistent with Thr being one of the major components of the amino-acid pool in L. tropica
promastigotes [257].
Thr can be synthesized de novo from Asp in a multistep pathway that involves aspartokinase
(AspK, EC 2.7.2.4), Asp semialdehyde dehydrogenase (AspSD, EC 1.2.1.11), and homoserine
dehydrogenase (HSD, EC 1.1.1.3), which culminates in homoserine production. Homoserine is then
phosphorylated by homoserine kinase (HSK, EC 2.7.1.39) and the resulting O-phospho-homoserine
is finally converted into Thr by Thr synthase (ThrS, EC 4.2.3.1) (Figure 8). Leishmania spp. genomes
encode all enzymes of this pathway, and the conversion of Asp into Thr has been demonstrated in
L. mexicana [258]. However, it has recently been reported that the absence of Thr in the culture medium
increases the doubling time of promastigotes, whilst it decreases the cellular protein content and size,
suggesting that the Thr de novo biosynthetic pathway is not sufficient for optimal parasite growth [85].
Interestingly, the T. brucei genome only encodes the last two steps of the pathway and an HSK has been
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characterized. Growth of the PCF HSK-null mutant is compromised in the absence of Thr and rescued
by the addition of homoserine [259]. Incidentally, the tsetse fly microbiota includes two species of
bacteria—Soldalis glossinidius and Wigglesworthia glossinidia—producing homoserine, which could be
a source of Thr in the T. brucei PCF in vivo, explaining why the last two steps of the pathway have
been retained.
3.7.4. Alanine
Ala constitutes the majority of the free amino acid pool in trypanosomes [260,261] and Leishmania
spp. [257]. It has been demonstrated in Leishmania that approximately 90% of the free Ala pool
corresponds to the L-isomer. The remaining part is formed by D-Ala that is synthesized by the activity
of the Ala racemase [262] (AlaR, EC 5.1.1.1). Putative coding sequences for Ala racemase are present
in both the T. cruzi and T. brucei genomes, but they still remain uncharacterized. Extracellular Ala
uptake has been demonstrated in T. b. gambiense [33] and L. donovani [78]. It can also be synthesized by
different pathways in trypanosomatids. In fact, Frydman and collaborators used 13C-nuclear magnetic
resonance to investigate Ala pools in T. cruzi epimastigotes. They were able to identify two distinct
pools: one originated from glucose metabolism and the other one from a different source [263].
In addition to uptake and synthesis, Ala is also excreted by trypanosomatids [264]. Actually,
the levels of this amino acid are increased in the serum, but not in tissues of mammals infected with
T. b. gambiense and T. brucei [265–267]. In PCF T. brucei, Ala is the main excreted product from Pro
metabolism when cells are grown in the absence of glucose. As mentioned earlier, the excreted Ala
is the product of the amination of pyruvate through the action of transaminases. The main known
sources of pyruvate are the conversion of malic acid through the mitochondrial or cytosolic malic
enzymes or the production from phosphoenolpyruvate by pyruvate kinase [94] (PK, EC 2.7.1.40).
T. brucei has a coding sequence for a putative mitochondrial ALAT, of which expression has been
detected in both the cytosol of both the PCF and BSF. It specifically transaminates Ala using α-KG as
an amino acceptor, generating pyruvate and Glu (Figure 5). Down-regulation of TbALAT induces a
strong growth defect of the PCF trypanosomes in glucose-depleted conditions, which confirms that
ALAT activity is essential for the viability of the parasite in the insect vector, where the availability of
glucose is limited [129,268,269].
In T. cruzi and L. donovani, ALAT is expressed throughout all stages of the life cycle, but higher
expression levels have been observed in amastigote stages [270]. TcALAT is localized in both the
mitochondrion and the cytosol [129]. The poorly specific TcTAT is also localized in the cytosol and,
therefore, the cytosolic pool of Ala/pyruvate might be regulated by the combined activity of these two
enzymes. Furthermore, as previously mentioned, in T. cruzi epimastigotes Ala can also be generated as
a product of Ser metabolism [239].
3.7.5. Lysine
Trypanosomatids are unable to synthesize Lys and rely on uptake to obtain this amino
acid [52,90,91]. Accordingly, Lys has been shown to be essential for cell growth in Leishmania [85].
In summary, a list of enzymes that use amino acids as substrates and their respective genes’
accession numbers in TriTryps is detailed in Table 2.
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Table 2. Genes annotated as encoding relevant amino acid metabolism enzymes in TriTryps.
Amino Acid Enzymes
Genes *
Characterization
T. brucei T. cruzi L. major
Ala ALAT Tb927.1.3950 TcCLB.506529.420 LmjF12.0630 [129,269]
AlaR Tb927.5.1280 TcCLB.509767.90 LmjF.23.1480 [262]
TAT (see aromatic AA)
Arg ARG - - LmjF.35.1480 [141]
ArgK Tb927.9.6210 TcCLB.482369.29 - [51,148,150]
Aromatic AA ASAT/BSAT Tb927.10.3660 TcCLB.503841.70 LmjF.35.0820 [171,174,228]
TAT - TcCLB.508535.50 LmjF.36.2360 [129]
Asn ASN - TcCLB.504147.110 LmjF.36.4430
Asp AS Tb927.7.1110 TcCLB.503899.90 LmjF.26.0830 [176]
ASAT (see aromatic AA)
mASAT Tb927.11.5090 TcCLB.510945.70 LmjF.24.0370 [174]
BCAA BCAT Tb927.2.4590 LmjF27.2030
TAT/ASAT (see aromatic AA)
Cys CGS Tb11.v5.0869 TcCLB.510741.10 LmjF14.0460 [215]
CD - - LmjF.32.2640 [216]
Gln GLNAT Tb927.10.11970 TcCLB.503747.10 LmjF.33.1330 [129]
GF6PA Tb927.7.5560 TcCLB.510303.200 LmjF.06.0950 [131]; Crispim et al., unpublished data
CPS Tb927.5.3800 TcCLB.508373.10 LmjF.16.0590 [126,127]
GMPS Tb927.7.2100 TcCLB.508085.10 LmjF.22.0110 [128]
Glu GDH Tb927.9.5900 TcCLB.505843.10 LmjF.15.1010 [119]
GS Tb927.7.4970 TcCLB.503405.10 LmjF.06.0370 [125,130]
P5CS - TcCLB.509067.70 LmjF.32.3140
TAT/ASAT (see aromatic AA)
Gly GCC-P Tb927.7.1910 TcCLB.510911.50 LmjF26.0030 [244]
His HAL - TcCLB.506247.220 - [61]
Lys - - - -
Met AdoMetS Tb927.6.4840 TcCLB.506945.160 LmjF.30.3500 [189,191]
MSR Tb427.08.550 TcCLB.510855.10 LmjF.07.1140
Pro PRODH Tb927.7.210 TcCLB.506411.30 LmjF.26.1610 [38,95]; Ferraz et al., unpublished data
PRAC - TcCLB.430737.10 -
Phe PAH - - LmjF.28.1280 [229]
Ser SHMT-L - - LmjF.28.2370 [241]
SHMT-S - TcCLB.510407.90 LmjF.14.1320 [241,243]
SAT TcCLB.510879.80 LmjF.34.2850 [210,216]
CBS Tb11.02.5400 TcCLB.508241.140 LmjF17.0250 [210,212]
Thr TDH Tb927.6.2790 TcCLB.507923.10 - [169]
Putative genes
* Accession numbers from reference strains: T. brucei TREU927, T. cruzi CL Brener Esmeraldo-like (except HAL) and L. major strain Friedlin.
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4. Non-Obvious Roles of Amino Acids
4.1. Host-Parasite Interaction
T. cruzi, along its life cycle, needs to adapt to different nutrients available in the different
environments: the bloodstream, the intracellular environments in the different tissues it can invade
in the mammalian host, and the different parts of the midgut in the insect vector. Epimastigotes
in the early exponential growth phase (in vitro) are equipped with the complete set of glycolytic
enzymes and, in fact, they obtain energy from glucose catabolism. However, it is not known if
this is possible inside the insect midgut, since relevant quantities of free sugars in this environment
have not been demonstrated so far [271]. However, the availability of amino acids has been well
demonstrated [272,273] and the ability of epimastigotes to catabolize these metabolites is well
understood, as previously described. In addition to their role in the parasite’s bioenergetics, it
was demonstrated that some of these amino acids have relevance in the survival of the epimastigotes
during the nutritional, redox, osmotic, and thermal stresses that they suffer in the midgut [274,275].
For example, Pro participates in the parasite’s resistance to thermal stress, while both Pro and Glu
contribute to resistance to the nutritional stress and redox imbalance [276,277]. Additionally, His
was shown to extend parasite survival in nutritional stress conditions, such as that experienced by
epimastigotes during the colonization of the triatomine midgut [61].
Nutritional stress also plays a functional role in T. cruzi’s life cycle. Metacyclogenesis, i.e.,
the differentiation of the proliferative non-infective epimastigotes into the non-proliferative infective
metacyclic trypomastigotes, is triggered when the epimastigotes are starved [172], followed by
exposure to a supply of nutrients, notably some amino acids. To analyze this process in more detail,
Contreras and collaborators developed a minimum medium for in vitro induction of metacyclogenesis.
They investigated the effect of individually adding 10 different L-amino acids to artificial triatomine
urine. In this study, Pro was the only amino acid able to support an approximately 90% efficient
differentiation [172], although subsequent experiments showed that Gln and Asn were also able to
induce metacyclogenesis, with efficiencies similar to that of Pro [278]. Interestingly, it was shown that
the consumption of amino acids continued after completion of metacyclogenesis [279].
Since the next differentiation step, of the non-dividing metacyclic trypomastigotes into
proliferating amastigotes occurs exclusively in the intracellular environment, invasion of host cells by
the trypomastigotes should be considered a crucial step for establishing the infection in the mammal.
The parasite requires energy for this host-cell invasion [280]. It was shown that this energy can be
provided by Pro, its metabolite P5C and, to a lesser extent, Glu, because these compounds were shown
to make the mammalian host-cells infection much more efficient [96,279].
Trypomastigote forms derived from a previous mammalian host-cell infection are, most of the
time, present in the glucose-rich bloodstream, and are able to consume this compound for their
energy metabolism [281]. Once the parasites establish the infection in the cytosol of the host cells
as amastigotes, they go through a metabolic switch to preferably consume the intracellular pools of
amino acids, mainly Pro, as carbon and energy source. In fact, the intracellular environment is poor
in glucose and amastigotes are unable to take this sugar up from an environment at concentrations
below the millimolar range [281], despite the fact that amastigotes can take up and metabolize glucose
when available at high concentrations [282]. It was also demonstrated that amastigotes can acquire
fatty acids from the host to support infection [283,284].
As mentioned earlier, the metabolism of amino acids occurs with the production of NH4+ as a
result of the transfer of the amino group to H2O [185]. As T. cruzi does not have a functional urea
cycle [113], the detoxification of the accumulated NH4+ occurs through its metabolism to form non-toxic
metabolites, notably through its incorporation into α-KG to form Glu. However, a high consumption
of α-KG to deal with NH4+ accumulation could compromise the functioning of the TCA cycle. Thus,
α-KG is regenerated by a transamination reaction in which pyruvate is the main amino group acceptor,
yielding also Ala [122]. As the accumulation of Ala can be detrimental as well, we proposed and
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recently demonstrated that the enzyme GS can contribute to the detoxification of NH4+. In fact, GS has
its highest activity in the amastigote stage and we showed its participation in the regulation of the
NH4+ release during the transient residence of T. cruzi in the parasitophorous vacuole [125]. The acidic
pH of this vacuole is critical for the parasite differentiation from trypomastigotes to amastigotes and for
the release of the amastigotes into the host-cell cytosol, a sine qua non condition for the establishment
of the intracellular infection [285]. Moreover, it was recently shown that intracellular parasite forms
possess transmembrane transporters their in acidic organelles to sequester the ammonium resulting
from amino-acid metabolism. This system enhances the parasite’s resistance to starvation and osmotic
stress [286].
The intracellular epimastigote is a transient stage between amastigote and trypomastigote,
and expresses some of the trypomastigote surface proteins, probably as an early adaptation to
the needs that trypomastigotes, the next stage, will face [5]. As such, its ability to transport glucose
from the medium (which is, in this case, the host-cell cytosol) is not surprising [281]. However, it was
shown that among all the stages analyzed so far, intracellular epimastigotes are those with the highest
specific activities of Pro uptake, PRODH and P5CDH, i.e., the enzymes involved in the oxidation of Pro
to Glu. This increase of Pro uptake serves probably to compensate for a decrease of the intracellular
stocks of free Pro due to its catabolism [95,96,101,281]. Even more, when the infection happens in a
Pro-poor environment, the total number of released trypomastigotes, as well as the differentiation from
intracellular epimastigotes to trypomastigotes, are compromised, indicating that Pro is involved
not only in the intracellular proliferation of the parasites, but also in their differentiation [101].
In addition, different studies suggested that the Pro-dependent enzyme TcPRAC is involved in
cellular differentiation and invasion [117,287] and in the development of the parasite’s resistance to the
host proteolytic enzymes through the incorporation of D-Pro into parasite proteins [288]. Remarkably,
the secreted isoform of TcPRAC, an enzyme having Pro as a substrate, is an effective mitogen for
host B lymphocytes, favoring parasite evasion of specific immune responses [115,116]. This activity
is dependent on the exposure of a transient epitope in the ligand-free enzyme [289]. Consequently,
the mitogen activity would be regulated by the availability of Pro in the mammalian host blood.
T. brucei also alternates between its mammalian host and insect vector and adapts its metabolism
to the availability of nutrients in these different environments. The BSF use glucose as an energy source
that is abundant in the mammalian blood [30,290,291]. Interestingly, it was recently shown that, in
spite of the existence of a fully-functional Gln biosynthesis pathway in long-slender BSF, the supply of
external Gln is essential for the BSF’s survival and replication (Damasceno et al., unpublished data).
Little is known about the differentiation process from metacyclic forms to the replicative long-slender
BSF. However, some more information is available on the differentiation process from long-slender BSF
to the non-proliferative and insect-infective stumpy BSF. This process is dependent on the parasitemia
level and on the concentration of the stumpy-induction factor (SIF) [292]. Although still of unknown
identity, it has been shown that SIF is a low molecular weight soluble molecule produced by the
parasite [8]. Transformation to the stumpy form induces a partial metabolic reprogramming including
the upregulation of various mitochondrial processes, like the induction of ASCT expression with
consequent acetate production. This likely creates a pre-adaptive condition to the next stage: the
infection of the insect vector [293]. Within approximately 15 minutes after the tsetse has taken up
stumpy BSF parasites during the blood meal, glucose from the host’s blood has been consumed [294].
In the midgut of the fly, Pro, the most abundant amino acid in the tsetse flies which energetically
supports the flight process [268], becomes the main energy source for PCF, as well as, to a lesser extent,
Thr. In fact, the need of a fully-functional Pro metabolic pathway for T. brucei survival in the insect’s
midgut and to support establishment of the fly’s infection was recently shown [38,39,94]. Similarly,
in vitro transformation from BSF to PCF involves addition of citrate/cis-aconitate to the differentiation
medium, which lacks glucose and is rich in Pro and Gln, and a change in temperature, which, together,
stimulate mitochondrial development, including the expression of TCA cycle enzymes [295,296].
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Leishmania spp. classically present two stages: amastigote (in the mammalian host) and
promastigote (in the insect vector). Proliferative promastigotes, in turn, can differentiate into
non-proliferative, infective metacyclic promastigotes, which are morphologically similar to the
proliferative ones [297]. The exponentially-growing promastigote expresses an enzymatic arsenal
to metabolize disaccharides, probably an adaptation to the diet of sandflies, which can feed
on nectar and aphid honeydew. Promastigotes face varying environmental conditions, like the
physical and chemical changes due to, respectively, the temperature and the nutritional habit of
the sandfly [298]. Comparative proteomic and metabolomic analyses of a mutant promastigote
line with inability to transport glucose suggest that Pro is a main carbon source used for energy
metabolism and gluconeogenesis [103]. The amastigote is the proliferative form and replicates inside
the phagolysosomal compartment of macrophages using mainly sugars as energy source, although it
presents a reduced uptake and rate of metabolism when compared to the promastigote form [299].
In fact, Leishmania spp. differentiate from the extracellular procyclic promastigotes to metacyclic
promastigotes in the sandfly and then to the intracellular amastigotes in the mammalian host. Similar
to T. cruzi, this transformation means an extreme change in environment, from the sand fly midgut to
the acidic interior of the phagolysosome. This process is accompanied by a metabolic switch in which
the parasite changes from the high use of sugars and amino acids as carbon and energy sources to a
form with a globally-reduced metabolism still based on the preferential use of sugars [300]. In fact,
the use of amino acids available in the phagolysosome appears to be detrimental, since it would
necessitate increased activity of the TCA cycle and respiratory chain resulting in oxygen stress for
which the parasites are highly susceptible in this environment [301].
In vitro differentiation of Leishmania spp. involves changes in temperature and pH [302], but the
function of amino acids in inducing cell differentiation is still to be elucidated. Diaz and collaborators
investigated the role of the L-amino acids Ala, Cys, Met, Glu, Gln, Pro, and Trp in inducing chemotaxis,
which has been proposed to be essential for cell differentiation. In this study, Glu, Gln, Met, and Trp
had both positive and negative effects on chemotaxis depending on the amino acid concentration,
suggesting the existence of some sort of sensing mechanism in Leishmania [303].
Arg plays a crucial role in the host-parasite interplay [304,305]: a mechanism in which Leishmania
senses extracellular levels of Arg has been shown to impact on parasite viability inside the macrophage.
The role of Arg during mammalian host-cell infection was studied in some detail. Arg is the substrate
of the inducible nitric oxide synthase (iNOS), a major effector of the immune system producing the
potent microbicidal NO, and which has an increased expression in activated macrophages [306]. Arg is
also a substrate for the enzyme ARG which, in both amastigotes and promastigotes, is found within
glycosomes, suggesting that the pool and trafficking of Arg is under control in these parasites [307].
Infection with L. major resulted in an additional increase of the parasite’s Arg catabolism through
ARG, producing two effects: diminishing the availability of free Arg as a substrate of the iNOS,
and re-directing this metabolite to the production of Orn and polyamines in the host cells. Interestingly,
upon diminished levels of Arg, the parasite upregulates the expression of the Arg “transceptor” AAP3,
to increase the uptake of the amino acid and compensate for the effect of its diminished levels
inside the host-cells [80,308,309]. In summary, inhibition of arginase activity results in diminished
Arg catabolism, decreased polyamine synthesis, and subsequently-reduced parasite growth [310],
whereas at the host side the amino acid Arg is the substrate to produce nitric oxide for combating the
parasite [305,309,311,312]. This metabolic balance can decide between death or survival of the parasite.
4.2. Role of Amino Acids in the Regulation of Autophagy and Apoptosis
As part of the attention being paid to “non-canonical roles” (i.e., beyond their involvement in
the cell bioenergetics or protein synthesis) of amino acids in trypanosomatids, efforts have been
made to elucidate their possible participation in regulating processes in these organisms, such
as autophagy and cell death. Schmidt and Butikofer used PCF T. brucei expressing GFP-tagged
TbAtg8.1 and TbAtg8.2 to investigate the conditions in which autophagy is induced in this organism.
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Atg8 is a cytosolic protein that, upon initiation of the autophagy process, is cleaved and modified
by the addition of a phosphatidylethanolamine (PE) anchor. This modification relocates Atg8 to the
developing phagophore membrane that will give rise to the autophagosomes, which will eventually
fuse with the lysosome [313–315]. The authors found that when PCF experiences nutrient starvation,
TbAtg8.1-GFP and TbAtg8.2-GFP presented a punctal appearance, spread throughout the cytoplasm.
However, addition of His prevented the relocation of the fluorescently-tagged proteins to puncta and
autophagy [316]. As previously mentioned, T. brucei does not have the canonic His degradation
pathway and, although the mechanism by which this amino acid protects trypanosomes from
autophagy is still to be elucidated, it is very likely that it is a direct effect of His and not of a product of
its catabolism. Conversely, among the amino acids are not only those that protect against autophagy,
but also ones that, by the trypanosome’s starvation for them, induce the process, similarly to what
has been reported for other eukaryotes. For example, He and collaborators described that amino
acid starvation can trigger autophagy independently of the AMP-activated-Protein-Kinase-mediated
energy sensing mechanisms [317,318]. Further studies are required to unravel the details of the
pathways involved.
A more explicit mechanism has been proposed to explain the role of Arg in protecting T. cruzi from
apoptosis. Piacenza and collaborators found that Arg prevents the formation of patterns associated
with the programmed cell death process as DNA fragmentation and inhibition of [3H]-thymidine
incorporation when epimastigotes are exposed to apoptotic stimuli. Furthermore, Arg stimulates the
mammalian host’s production of NO, which is a known apoptosis regulator [319] and polyamine
synthesis that sustains parasite proliferation [320]. Similarly, the absence of Arg in culture media
has been associated with oxidative stress, increase in reactive oxygen species production, decrease in
polyamine synthesis, and induction of programmed cell death in L. donovani promastigotes [321].
4.3. Osmotic Control by Amino Acids
Amino acids, besides being precursors of essential compounds, such as polypeptides and
polyamines, also function as osmolytes used by the TriTryps to cope with the osmotic stress that
they face along their life cycles. When insect forms colonize the digestive tract of their invertebrate
hosts, they encounter extreme fluctuations in osmolarity caused by the regular feeding of the bugs
and, particularly in the case of metacyclic forms of T. cruzi, by the composition of the triatomine
rectal contents [322–325]. In the vertebrate hosts, the parasites still face osmotic fluctuations, since
different tissues are exposed to high or low osmolarity fluids in their physiological or pathological
conditions [326,327]. Therefore, osmoregulation is essential for the completion of the biological cycle
by the TriTryps.
Osmotic control in trypanosomatids is mainly performed by two types of organelles: the
acidocalcisomes in all trypanosomatids and in T. cruzi the contractile vacuole complex [328,329].
Acidocalcisomes are electron-dense acidic organelles that are rich in calcium and polyphosphates [330].
The contractile vacuole complex is a bipartite structure composed of a network of microtubules and
vesicles named the spongiome, surrounding a central vacuole, or bladder [331]. This bladder swells
when it accumulates excess water from the cytosol, which is eventually expelled from the cell after the
bladder comes into contact with the plasma membrane [332]. In T. cruzi, the hydrolysis or synthesis of
polyphosphates inside the acidocalcisomes occurs in response to hypoosmotic or hyperosmotic stress
conditions, respectively [333]. In L. major the acidocalcisomal content also changes under hypoosmotic
stress, changing its levels of sodium and chlorine [334]. In T. brucei, the role of acidocalcisomes in
osmoregulation has been demonstrated in a mutant cell line deficient in polyphosphate production
that became sensitive to osmotic stress [335].
Pools of amino acids in TriTryps also provide a reservoir of osmolytes for cells to use during
osmotic stress. Under hypoosmotic stress, amino acids are mobilized for an intensive efflux to exhibit
a regulatory volume response [336–338]. This efflux occurs through an anion channel, mobilizing
uncharged and acidic amino acids, a mechanism that accounts for approximately 50% of the regulatory
Pathogens 2018, 7, 36 28 of 45
volume decrease [328]. Epimastigote, amastigote, and trypomastigote forms of T. cruzi released
Glu, Gly, and, mainly, Ala and Pro [337], while promastigotes of L. major released Glu, Gly, Ser,
and mainly Ala, which is also the major amino acid released by amastigotes of L. donovani [336,338].
The importance of amino acids as osmolytes was also evidenced in hypoosmotic and hyperosmotic
stresses, by noticing an increase of the catabolism or biosynthesis under the respective stress conditions
that serves to maintain the cytosolic ionic strength [339,340].
More recently, Inbar et al. have shown that Pro and Ala act differently in the face of hypoosmotic
stress in L. donovani, with Pro only influencing the rate of volume decrease, while Ala is involved in
controlling the extent of swelling. The authors also suggested that the regulatory volume decrease is
mediated by Pro, either through its flow along with the water flow, or associated with activation of a
water channel, possibly aquaporin 1 [78].
All functions of amino acids that have been described in TriTryps and mentioned in this review
are summarized in Table 3.
Table 3. Functions associated to amino acids in TriTryps.
Amino Acid Function T. brucei T. cruzi Leishmania spp. References
Ala Osmotic control [336–338]
Arg
Polyamine biosynthesis [134,136]
Establishment of infection [306]
Apoptosis protection [320]
Energy management [51,148,149]
Asn Metacyclogenesis [278]
Asp
Metacyclogenesis [172]
Pyrimidine biosynthesis [175]
Mitochondrial ATP synthesis [93]
Cys Trypanothione synthesis [214]
Gln
Pyrimidine biosynthesis [126,127]
Hexosamine biosynthesis Crispim et al., unpublished; [131]
Metacyclogenesis Damasceno et al., submitted
Glu
Osmotic control [336–338]
Metacyclogenesis [172]
Mitochondrial ATP synthesis [93,121]
Resistance to oxidative stress [277]
Resistance to nutritional stress [277]
Gly Osmotic control [336–338]
His
Resistance to nutritional stress [61]
Autophagy protection [316]
Leu
Sterol biosynthesis [165,167]
Fatty acid biosynthesis [165]
Met
Polyamine biosynthesis [173]
Resistance to oxidative stress [197,204,205]
Pro
Mitochondrial ATP synthesis [2,38,39,92,95,96]
Carbon source [2,30,38,103]
Cell differentiation [101,172]
Cell invasion [96,279,337]
Osmotic control [337]
Resistance to oxidative stress [276]
Resistance to thermal stress [276]
Resistance to nutritional stress [276]
Ser Osmotic control [336,338]
Thr Carbon source [169,256]
5. Concluding Remarks
TriTryps transit during their life cycle through different environments, thus being exposed to
variations in their nutritional situations and challenged by a variety of stress conditions. Amino acids
are present at different concentrations and ratios in each of the environments and exert different roles
in the parasites in the successive life-cycle stages. Amino acids are a group of metabolites with an
amazing diversity in their physicochemical properties. In fact, most of physicochemical conditions
of any cellular or subcellular microenvironment (such as pH, redox potential, osmolarity) could be
created or regulated by using different combinations of amino acids and their intermediate metabolites.
In addition to being taken up or synthesized for their role as constituents of proteins, amino acids
participate in a myriad of biological processes, such as cell bioenergetics, the regulation of cell cycle,
regulation of cell volume, mechanisms of cell survival (autophagy) and death, differentiation, and cell
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invasion. Even more, in some cases, the regulation of amino acids and their metabolism can subvert the
host immune response. The regulation of these activities is dependent on several factors, mainly their
uptake, degradation, and biosynthesis. These activities can also be determined by the accumulation
of intermediate metabolites, which, in many cases, were shown to be much more than inert entities
in the route from precursor to the product of a metabolic pathway. A more detailed knowledge
on this intricate metabolic network is necessary to improve our understanding of the biology of
these organisms.
Supplementary Materials: The following item is available online at http://www.mdpi.com/2076-0817/7/2/36/s1,
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